WO2007129698A1 - Chemical transpiration apparatus - Google Patents

Chemical transpiration apparatus Download PDF

Info

Publication number
WO2007129698A1
WO2007129698A1 PCT/JP2007/059488 JP2007059488W WO2007129698A1 WO 2007129698 A1 WO2007129698 A1 WO 2007129698A1 JP 2007059488 W JP2007059488 W JP 2007059488W WO 2007129698 A1 WO2007129698 A1 WO 2007129698A1
Authority
WO
WIPO (PCT)
Prior art keywords
light
drug
transpiration
light source
hue
Prior art date
Application number
PCT/JP2007/059488
Other languages
French (fr)
Japanese (ja)
Inventor
Yasuyuki Hasegawa
Hitoko Matsunaga
Original Assignee
Kobayashi Pharmaceutical Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kobayashi Pharmaceutical Co., Ltd. filed Critical Kobayashi Pharmaceutical Co., Ltd.
Publication of WO2007129698A1 publication Critical patent/WO2007129698A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M21/02Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis for inducing sleep or relaxation, e.g. by direct nerve stimulation, hypnosis, analgesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L9/00Disinfection, sterilisation or deodorisation of air
    • A61L9/015Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone
    • A61L9/02Disinfection, sterilisation or deodorisation of air using gaseous or vaporous substances, e.g. ozone using substances evaporated in the air by heating or combustion
    • A61L9/03Apparatus therefor
    • A61L9/037Apparatus therefor comprising a wick
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0016Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the smell sense
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M21/00Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis
    • A61M2021/0005Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus
    • A61M2021/0044Other devices or methods to cause a change in the state of consciousness; Devices for producing or ending sleep by mechanical, optical, or acoustical means, e.g. for hypnosis by the use of a particular sense, or stimulus by the sight sense

Definitions

  • the present invention relates to a chemical transpiration apparatus for evaporating an aromatic component.
  • Patent Document 1 discloses an arousal perfume composition containing an Oris-based fragrance, a sandalwood-based fragrance, and a rose-based fragrance.
  • Patent Document 1 JP-A-7-316582
  • an object of the present invention is to provide a drug transpiration device that can effectively enhance the hypnotic action.
  • the object of the present invention includes a carrier impregnated with a chemical containing an aroma component, a device main body containing the carrier, and a light source disposed inside the device main body.
  • the mounting body has a transpiration port for transpiration of the fragrance component to the outside, and a light transmission part that transmits the wakefulness light emitted from the light source to the outside, and the wakefulness light that has passed through the light transmission part is: ,
  • the illuminance is! :! To 36 lux
  • the hue is a PCCS hue ring with a hue number of 7 to 15 and the fragrance component is achieved by a chemical transpiration apparatus containing a woody fragrance component as a main component.
  • PCCS Practical Color Co-ordinate System
  • the PCCS hue circle consists of 24 hues with hue numbers 1 to 24 arranged in a circle, with the psychological primary colors (red, yellow, green, and blue) as the basis for hue division.
  • fragrance component those containing a woody fragrance component as a main component are suitable, but the main component here is as long as the woody fragrance can be discriminated by smell. It is the meaning which accept
  • the chemical vaporization apparatus further includes a heating element that heats the carrier accommodated in the apparatus main body and promotes the vaporization of the aromatic component.
  • the light transmission part includes a scattering part that scatters the sleeping light.
  • the scattering part may include a part formed of a light semi-transmissive material in the light transmission part.
  • the light transmission portion is formed on the opposite side of the power plug at least with the light source interposed therebetween.
  • the apparatus main body may include a base body made of a light reflective material and a force bar portion having the light transmission portion.
  • the cover part is disposed with a gap between the base and the base so as to cover the whole base, and the light source emits illumination light into the gap between the base and the cover. It is preferable that they are arranged as described above.
  • the light transmission part is formed in a curved plate shape and is bent inward as viewed from the light source side.
  • the hypnotic action can be effectively enhanced.
  • FIG. 2 is a plan view of a chemical transpiration apparatus according to an embodiment of the present invention
  • FIG. 2 is a side view partially showing the AA cross section of FIG.
  • the chemical evaporation apparatus 1 includes an apparatus main body 2 composed of a base body 10 and a cover portion 20, and a carrier 4 that is detachably accommodated inside the apparatus main body 2. And a light source 6 disposed inside the apparatus main body 2.
  • the base 10 is formed in a container shape from a light reflective material, and the upper opening is covered with a lid member 11.
  • the light reflective material is not particularly limited as long as it is a material having visible light reflectivity.
  • a white pigment or a dye is dispersed in various resins such as an acrylic resin, a polyethylene resin, and a polycarbonate resin. And metal materials such as stainless steel and aluminum.
  • the lid member 11 can be formed of a resin having excellent heat resistance and electrical insulation, and includes a storage portion 12 that can store the carrier 4 by being partially recessed.
  • a metal bottomed cylindrical heat transfer body 13 is fitted to the outer peripheral surface of the housing part 12, and the bottom surface of the bottom part of the heat transfer body 13 has a planar shape made of an electric heater such as a PTC heater.
  • the heating element 14 is installed in close contact.
  • the base 10 has a discharge port 10a formed at the bottom, and the light source 6 is disposed so as to emit a drowsiness light downward through the discharge port 10a.
  • Awakening light refers to light that causes a sleep-inducing action, and is light that has lower illuminance than light intended for normal illumination. Specific illuminance of the sleeping light will be described later.
  • a green light emitting diode is used as the light source 6 that emits the sleeping light, but other lighting devices such as a fluorescent lamp, a neon tube, and an incandescent bulb may be used.
  • a power plug 16 and a switch 17 are provided on the side surface of the base 10, and the heating element 14 and the light source 6 can be energized via the power plug 16.
  • the operation of the switch 17 allows the power S configured to energize the heating element 14 and the light source 6 in a body, and the energization of the heating element 14 and the light source 6 can be performed individually. You may comprise as follows.
  • the cover portion 20 is made of a light-transmitting material, is disposed so as to cover the entire base 10, and the power plug 16 and the switch 17 protrude through the openings 20a and 20b, respectively.
  • the transmissive material is not particularly limited as long as it is a material having at least visible light translucency so that the sleeping light can be visually recognized outside.
  • Examples of such a light transmissive resin, ceramics, glass, and the like, and a light semi-transmissive material such as a resin in which an appropriate amount of a pigment or a dye is dispersed in these resins, or polished glass are also included.
  • Positioning of the base body 10 with respect to the cover part 20 is performed by fitting the power plug 16 into the opening 20a. In this state, there is a gap between the base body 10 and the cover part 20 over the whole. It is formed.
  • the cover part 20 includes a cap 21 that detachably covers the upper part of the base body 10, and the carrier 4 can be accommodated in the accommodating part 12 with the cap 21 removed.
  • a transpiration port 22 for evaporating the medicine of the carrier 4 to the outside is formed immediately above the accommodating portion 12 in the cap 21.
  • a plurality of vent holes 23 are formed on the side surface of the cover part 20, and outside air is introduced between the base body 10 and the cover part 20 as the medicine evaporates from the evaporating hole 22.
  • the carrier 4 is a rod-like member made of felt, pulp, or the like, and is accommodated in the accommodating portion 12 so that the tip portion protrudes slightly.
  • the carrier 4 can be impregnated with various liquid chemicals such as insecticides, bactericides, fragrances, deodorants and the like containing additives as appropriate.
  • a product impregnated with a chemical containing at least the resulting fragrance component As such a fragrance component, woody fragrances such as “sandalwood” and “pine” are particularly suitable.
  • the material of the carrier 4 is cotton, rayon, acetate, synthetic resin (polyethylene, polypropylene, polyethylene + polypropylene mixture, polyethylene terephthalate, melamine, etc.), non-woven fabric, asbestos, inorganic molding, etc.
  • a felt core, an unglazed core, a pulp core, a synthetic resin core, or an inorganic molded core is preferred.
  • the shape of the carrier 4 is not limited to the rod-like shape as in the present embodiment, and may be various shapes such as a flat plate shape and a ring shape.
  • the power plug 16 is connected to an outlet installed on the wall surface of a home or office in a state where the carrier 4 is accommodated in the accommodating portion 12 of the apparatus body 2.
  • the heating element 14 and the light source 6 can be energized.
  • the heating element 14 heats the carrier 4 via the heat transfer body 13 and the accommodating portion 12.
  • evaporation of the aroma component impregnated in the support 4 is promoted, and the evaporated aroma component is evaporated to the outside through the evaporation port 22.
  • the sleeping light is emitted between the base 10 and the cover part 20 from the bottom of the base 10 downward.
  • This slumber light passes through the cover part 20 made of a light-transmitting material while being repeatedly reflected on the surface of the base substance 10 made of a light-reflective material in the gap between the base body 10 and the cover part 20, thereby Released from the whole to the outside.
  • the drug transpiration apparatus 1 of the present embodiment can effectively enhance the arousal action by the synergistic effect of the arousal action by the transpiration of the aromatic component and the arousal action by the release of the arousal light. is there.
  • the hue of the sleeping light transmitted through the cover part 20 is more preferably a hue number 11 to 13 (green) which is preferably a hue number of 7 to 15 (yellow to dark green) in the PCCS hue ring.
  • the light intensity of the hypnotic light is too large, it may interfere with the hypnotic effect, while if it is too small, the effect of combining the hypnotic light with fragrance is difficult to obtain. Is more preferred to be 11 to 23 lux.
  • the illuminance of the sleeping light is the position 5 cm away from the position P closest to the light source 6 on the cover 20 surface of the chemical transpiration device 1 when the ambient illumination is 6 lux or less.
  • illuminance meter part number "ANA-F9", TOKYO
  • the illuminance of the sleeping light can be configured to be adjustable by providing a light intensity adjustment means such as a switch that can control the number of light sources 6 to be energized and the amount of power to be applied to the light sources 6.
  • the illuminance can be set to an optimal value according to the illuminance and individual differences.
  • woody perfume component By evaporating the woody perfume component under such arousal light having hue and illuminance, a particularly great arousal effect can be achieved.
  • woody fragrances include sandalwood, cedarwood, pine, guaiatuk, benzoin, abies, lava, cypress, and black moji. Extraction of plant-derived essential oils exemplified in these The exit site is the trunk and root of the tree.
  • Such an optimal combination of the type of fragrance and the hue and intensity of the awakening light is not obtained by simply combining those individually optimized.
  • the light with a hue number of 7 to 15 in the PCCS hue ring corresponds to the color of yellow to dark green and has been conventionally known as an obstacle to falling asleep.
  • the knowledge that a remarkable arousal effect can be obtained by setting it significantly lower than before and combining it with woody fragrances was first obtained by the present inventors conducting experiments with various combinations. It is.
  • the entire cover portion 20 may constitute the light transmission portion only in a part of the force constituting the light transmission portion that emits the sleeping light to the outside.
  • the light transmitting part may be provided with a scattering part that scatters the sleeping light from the light source 6, so that soft light can be emitted substantially uniformly from the entire scattering part. It becomes possible and can enhance the awakening effect.
  • scattering refers to a phenomenon in which awakening light is refracted or reflected at the scattering portion and diffused in various directions.
  • the scattering portion include a configuration including a portion formed of a light translucent material in the light transmission portion, a configuration including an uneven portion provided on one or both of the inner surface side and the outer surface side of the light transmission portion, Examples thereof include a structure containing fine particles dispersed inside a light transmissive resin or glass constituting the light transmissive part, and a structure in which two or more of these are combined may be used. Fine particles include pigments, dyes, and bubbles.
  • the visible light transmittance of the light transmitting part is too high, visible light is hardly reflected inside the apparatus body 2 and is emitted to the outside. On the other hand, if it is too small, the illuminance may decrease, so 40-80% force S is preferable, and 50-70% is more preferable.
  • the heating element 14 is energized to heat the carrier 4 to promote the evaporation of the drug impregnated in the carrier 4, but the heating element 14 is not provided.
  • a gap is formed between the base 10 made of a light-reflective material and the cover 20 made of a light-transmitting material, and the user is asleep from the bottom of the base 10 downward.
  • the light source 6 By emitting light, it is configured to promote the release from the entire cover part 20 and to ensure the awakening effect by combining the fragrance and the awakening light, but the light source that emits the awakening light 6
  • the arrangement of the light source 6 is not necessarily limited to that of the present embodiment.
  • the light source 6 may be arranged so as to emit the sleeping light from the side portion of the base body 10 into the gap between the base body 10 and the cover part 20.
  • the cover portion 20 may be configured not to be provided as it is not necessary.
  • a single light source 6 is arranged.
  • a plurality of light sources 6 may be arranged. Even in this case, it is possible to make the whole light gently by adopting the configuration including the scattering portion as described above.
  • FIG. 3 a configuration shown in FIG. 3 can be exemplified.
  • the same components as those in FIGS. 1 and 2 are denoted by the same reference numerals, and detailed description thereof is omitted.
  • the drug transpiration apparatus 100 is configured by accommodating a drug container 40 holding a rod-shaped carrier 4 in an apparatus main body 200 including a main body 201 and a cover 202.
  • the main body section 201 is made of a light reflecting material
  • the cover section 202 is made of a light transmitting material
  • the cover section 202 constitutes a light transmitting section of the apparatus main body 200.
  • the drug container 40 can be made of glass, for example, and stores a liquid drug L having an aromatic component therein.
  • the main body 201 includes a holding unit 201a that holds the upper portion of the carrier 4 and the drug container 40 at predetermined positions, and further includes a heater 201b and a fan 201c. Further, the force bar portion 202 has a transpiration port 22 formed at a position facing the fan 201c, and is fitted to the main body portion 201.
  • a light source 6 and a projecting piece 202a are provided on the inner surface side of the cover part 202, and the projecting piece 202a is engaged with an engaging part formed on the outer side surface of the side wall of the medicine container 40.
  • the medicine container 40 can be inserted between the main body portion 201 and the cover portion 202 from below, and is detachably supported by engagement with the protruding piece 202a.
  • the cover part 202 constituting the light transmission part is shaped so as to bend inward as viewed from the light source 6 side. It is configured so that the sleep light of the light source 6 can be easily emitted from the entire cover portion 202.
  • a design sheet 50 is attached to the outer surface of the cover portion 202.
  • the design sheet 50 is formed by applying a design or a photograph to a sheet made of a light transmissive material such as a light transmissive resin or glass by means of printing or sticking, and is provided on a side edge. By inserting (not shown) into an insertion slit (not shown) of the cover portion 202, the cover portion 202 is held so as to be tightly attached.
  • the design sheet 50 may be attached to the cover portion 202 in a removable manner or may be integrated.
  • the calo heat heater 201b, the fan 201c, and the light source 6 are energized by the operation of the switch 17 by attaching the power plug 16 to the wall outlet.
  • the carrier 4 is accommodated in the apparatus main body 200 in a state where the drug U is immersed in the drug container 40, and the drug to be evaporated is supplied from the drug container 40. Can be sucked up and refilled. Therefore, it is possible to maintain the awakening effect for a long time by combining the release of the awakening light by the light source 6 and the transpiration of the drug.
  • the design sheet 50 is arranged in the light transmitting portion, a desired design or photograph can be lifted by the wake-up light, and the wake-up action can be promoted from the design effect.
  • the transmission part in the chemical evaporation apparatus 100 is formed in a part of the apparatus main body 200, and is formed on the opposite side of the power plug 16 with the light source 15 interposed therebetween.
  • the transmission part in the chemical evaporation apparatus 100 is formed in a part of the apparatus main body 200, and is formed on the opposite side of the power plug 16 with the light source 15 interposed therebetween.
  • the temperature and humidity chamber was maintained at a temperature of 23.5 to 24.2 ° C, a humidity of 43 to 46%, and an ambient illuminance of 0 to 6 lux.
  • the illuminance of the awakening light was set to 23 lux at a position 5 cm vertically below the P point force in Fig. 2, and the distance from the drug transpiration device to the subject was set in the range of 0.5 to 1. Om. .
  • the hypnotic light has hue numbers corresponding to red:! To 3, hue numbers corresponding to orange 4 to 6, hue numbers 7 to 10 corresponding to yellow, hue numbers 11 to 13 corresponding to green, Hue number 14 ⁇ : 15 corresponding to dark green, hue number 16 ⁇ 19 corresponding to blue, hue number 20 ⁇ 24 corresponding to purple, a total of 7 types, and fragrance is “Sandalwood” as woody fragrance And “Pine”, “lavender” and “Gerayuum” as herbal flavors, and “Rose” and “Linden” as floral flavors.
  • paste white paper Askul Multi-Paper Super Economy (weight: approx. 64g / m 2 paper thickness: approx. 90 / m whiteness: approx. 87%)) to point P in Figure 2. From the position opposite to the light source 6 with respect to this white paper, the colors appearing on the white paper were visually evaluated by five panelists.
  • the degree of relaxation is rated on a 7-point scale, with 6 points when you are very relaxed, 5 points when you are relaxed, and 4 points when you are relaxed. “3 points” if you could n’t relax, “1 points” if you could n’t relax, and “0 points” if you could n’t relax at all. did.
  • the present inventors have confirmed in advance that the degree of relaxation measured in this way has a correlation with the degree of the hypnotic effect.
  • Fig. 4 shows the results of this experiment.
  • the fragrance is a woody fragrance of “Sandalwood” and “Pine”
  • the awakening light is yellow light
  • green light or dark green light that is, the hue number is 7 to : 15
  • a combination of sedative light especially a combination of woody fragrance and green light (ie, hue number 11-13)
  • Fig. 3 a more remarkable lattus effect (sleeping effect) was obtained. From this result, it was found that the same woody fragrances such as Cedarwood, Guaiatucu, Benzoin, Abies, Hiba, Hinoki, Chromoji, etc.
  • the experiment was performed in the bedrooms of five subjects, and the ambient illuminance was 0 to 6 lux.
  • the distance from the drug evaporating device to the sleeping subject was set in the range of 0.5 to: 1. Om.
  • the illuminance of the hypnotic light is measured at a position 5 cm vertically downward from the point P in Fig. 2.
  • the subject was asked to ⁇ OSA sleep for middle-aged and elderly people.
  • Development and Standardization of Survey Form (MA Version) In accordance with Brain and Psychiatric Medicine No. 10 No. 4, 1999, we requested that the “OSA Sleep Survey Form MA Version” be completed immediately after waking up.
  • the “OSA Sleep Survey Form MA version” consists of 20 questions, including “Remaining fatigue” and “Concentration”. Each item is selected from four options. From these results, scores can be calculated for each of the five sleep-related factors (wake-up sleepiness, falling asleep and sleep maintenance, dreams, recovery from fatigue, and sleep time).
  • Figure 5 shows the results of calculating the average score of five subjects for each factor for each illuminance.
  • conditions 2 to 6 indicate cases where the illuminance of the sleeping light is 0 lux, 11 norletus, 23 lux, 36 lux, and 45 lux, respectively.
  • Condition 1 is a comparative example for these cases, in which neither the sleeping light nor the fragrance is used.
  • the illuminance of the second factor which is highly related to the hypnotic effect, is 11 to 36 lux.
  • a good hypnotic effect is obtained in the range of tuss, especially in the range of 11 to 23 lux.
  • the improvement effect was also confirmed for the first factor (wake-up sleepiness) and the fourth factor (fatigue) compared to other illuminance cases.
  • FIG. 1 is a plan view of a chemical transpiration apparatus according to an embodiment of the present invention.
  • FIG. 2 is a side view showing the section in the AA section of FIG.
  • FIG. 3 is a side view showing in partial cross section a drug transpiration apparatus according to another embodiment of the present invention.
  • FIG. 4 Experimental data showing the effect of the present invention on hypnosis.
  • FIG. 5 is another experimental data showing the effect of sleeping according to the present invention.

Abstract

[PROBLEMS] To provide a chemical transpiration apparatus capable of effectively enhancing hypnotic properties. [MEANS FOR SOLVING PROBLEMS] There is provided a chemical transpiration apparatus comprising support (4) impregnated with a chemical containing an aroma component, apparatus frame (2) accommodating the support (4) and light source (6) disposed within the apparatus frame (2), wherein the apparatus frame (2) has transpiration port (22) for outside transpiration of the aroma component and a light transmission part for outside radiation of hypnotic light by the light source (6), and wherein the hypnotic light having passed through the light transmission part exhibits an illuminance of 11 to 36 lux and a hue of 7 to 15 in terms of hue number in PCCS hue circle, and wherein the aroma component contains a woody perfume component as a main component.

Description

明 細 書  Specification
薬剤蒸散装置  Chemical transpiration device
技術分野  Technical field
[0001] 本発明は、芳香成分を蒸散させる薬剤蒸散装置に関する。  [0001] The present invention relates to a chemical transpiration apparatus for evaporating an aromatic component.
背景技術  Background art
[0002] 薬剤蒸散装置は、殺虫、殺菌、芳香、消臭など種々の目的のために従来から使用 されている。蒸散させる薬剤として、誘眠作用を生じさせるものが公知であり、例えば 、特許文献 1には、オリス系香料、サンダルウッド系香料及びローズ系香料を含む誘 眠香料組成物が開示されている。  [0002] Drug transpiration devices have been conventionally used for various purposes such as insecticide, sterilization, aroma, and deodorization. As a drug to be transpired, those that cause an arousal effect are known. For example, Patent Document 1 discloses an arousal perfume composition containing an Oris-based fragrance, a sandalwood-based fragrance, and a rose-based fragrance.
特許文献 1 :特開平 7— 316582号公報  Patent Document 1: JP-A-7-316582
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0003] ところが、誘眠作用を有する芳香成分は、蒸散量に比例して誘眠効果が高まるもの ではないため、芳香成分の蒸散のみによる誘眠作用の改善には限界があった。 [0003] However, since an aroma component having a hypnotic action does not increase the hypnotic effect in proportion to the amount of transpiration, there is a limit to the improvement of the hypnotic action only by transpiration of the aroma component.
[0004] そこで、本発明は、誘眠作用を効果的に高めることができる薬剤蒸散装置の提供を 目的とする。 [0004] Therefore, an object of the present invention is to provide a drug transpiration device that can effectively enhance the hypnotic action.
課題を解決するための手段  Means for solving the problem
[0005] 本発明の前記目的は、芳香成分を含有する薬剤を含浸させた担持体と、前記担持 体を収容する装置本体と、前記装置本体の内部に配置された光源とを備え、前記装 置本体は、前記芳香成分を外部に蒸散させるための蒸散口と、前記光源から放出さ れた誘眠光を外部に透過する光透過部とを有し、前記光透過部を透過した誘眠光 は、照度が:!:!〜 36ルクスであり、且つ、色相が PCCS色相環で色相番号 7〜: 15であ り、前記芳香成分は、ゥッディー系の香料成分を主成分として含む薬剤蒸散装置に より達成される。 [0005] The object of the present invention includes a carrier impregnated with a chemical containing an aroma component, a device main body containing the carrier, and a light source disposed inside the device main body. The mounting body has a transpiration port for transpiration of the fragrance component to the outside, and a light transmission part that transmits the wakefulness light emitted from the light source to the outside, and the wakefulness light that has passed through the light transmission part is: , The illuminance is! :! To 36 lux, and the hue is a PCCS hue ring with a hue number of 7 to 15 and the fragrance component is achieved by a chemical transpiration apparatus containing a woody fragrance component as a main component.
[0006] 誘眠光の照度は、環境照度が 6ルクス以下の場合に、光透過部の表面における光 源から最も近い位置から光源の放出方向に 5cm離れた測定位置において、照度計 を用いて測定した値である。 [0007] また、 PCCS (Practical Color Co-ordinate System)とは、財団法人日本色彩研究 所が開発した表色系で、色相及びトーンによって色を分類するものであり、実用的な 観点から広く利用されている。 PCCS色相環は、心理四原色(赤、黄、緑、青)を色相 分割の基本として、色相番号 1〜24からなる 24種類の色相を環状に配置したもので ある。 [0006] When the ambient illuminance is 6 lux or less, the illuminance of the sleeping light is measured using a luminometer at a measurement position 5 cm away from the light source on the surface of the light transmission part in the light source emission direction. It is the value. [0007] PCCS (Practical Color Co-ordinate System) is a color system developed by the Japan Color Research Institute, which classifies colors by hue and tone and is widely used from a practical standpoint. Has been. The PCCS hue circle consists of 24 hues with hue numbers 1 to 24 arranged in a circle, with the psychological primary colors (red, yellow, green, and blue) as the basis for hue division.
[0008] また、芳香成分については、ゥッディー系の香料成分を主成分として含むものが好 適であるが、ここでの主成分とは、ゥッディー系の香りを臭覚により判別可能である限 り、他の芳香成分を含むことを許容する趣旨である。  [0008] In addition, as the fragrance component, those containing a woody fragrance component as a main component are suitable, but the main component here is as long as the woody fragrance can be discriminated by smell. It is the meaning which accept | permits containing another aromatic component.
[0009] 上記の薬剤蒸散装置は、前記装置本体に収容された前記担持体を加熱して前記 芳香成分の蒸散を促す発熱体を更に備えることが好ましい。  [0009] It is preferable that the chemical vaporization apparatus further includes a heating element that heats the carrier accommodated in the apparatus main body and promotes the vaporization of the aromatic component.
[0010] また、液状である前記薬剤を貯留する薬剤容器を更に備えることも可能であり、この 場合、前記担持体は、その一部が前記薬剤容器内の薬剤に浸漬されている構成に すること力 Sできる。  [0010] Further, it is possible to further include a drug container for storing the liquid drug, and in this case, a part of the carrier is immersed in the drug in the drug container. That power S.
[0011] また、前記光透過部は、前記誘眠光を散乱させる散乱部を備えることが好ましい。こ の場合、前記散乱部は、前記光透過部において光半透過性材料により形成された 部分を含むことができる。  [0011] In addition, it is preferable that the light transmission part includes a scattering part that scatters the sleeping light. In this case, the scattering part may include a part formed of a light semi-transmissive material in the light transmission part.
[0012] また、前記装置本体が電源プラグを備える構成においては、前記光透過部が、少な くとも前記光源を挟んで前記電源プラグと反対側に形成されていることが好ましい。  [0012] Further, in the configuration in which the apparatus main body includes a power plug, it is preferable that the light transmission portion is formed on the opposite side of the power plug at least with the light source interposed therebetween.
[0013] また、前記装置本体は、光反射性材料からなる基体と、前記光透過部を有する力 バー部とを備えることができる。この構成においては、前記カバー部は、前記基体全 体を覆うように、前記基体との間に隙間をあけて配置され、 前記光源は、前記基体 とカバー部との隙間に照明光を放出するように配置されることが好ましい。  [0013] The apparatus main body may include a base body made of a light reflective material and a force bar portion having the light transmission portion. In this configuration, the cover part is disposed with a gap between the base and the base so as to cover the whole base, and the light source emits illumination light into the gap between the base and the cover. It is preferable that they are arranged as described above.
[0014] また、前記光透過部は、曲板状に形成されており、前記光源側からみて内側に湾 曲していることが好ましい。  [0014] Further, it is preferable that the light transmission part is formed in a curved plate shape and is bent inward as viewed from the light source side.
発明の効果  The invention's effect
[0015] 本発明の薬剤蒸散装置によれば、誘眠作用を効果的に高めることができる。  [0015] According to the drug transpiration apparatus of the present invention, the hypnotic action can be effectively enhanced.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0016] 以下、本発明の実態形態について添付図面を参照して説明する。図 1は、本発明 の一実施形態に係る薬剤蒸散装置の平面図であり、図 2は、一部を図 1の A— A断 面で示す側面図である。 [0016] Hereinafter, actual forms of the present invention will be described with reference to the accompanying drawings. Figure 1 shows the present invention. 2 is a plan view of a chemical transpiration apparatus according to an embodiment of the present invention, and FIG. 2 is a side view partially showing the AA cross section of FIG.
[0017] 図 1及び図 2に示すように、薬剤蒸散装置 1は、基体 10及びカバー部 20から構成さ れる装置本体 2と、装置本体 2の内部に着脱自在に収容される担持体 4と、装置本体 2の内部に配置された光源 6とを備えている。  As shown in FIGS. 1 and 2, the chemical evaporation apparatus 1 includes an apparatus main body 2 composed of a base body 10 and a cover portion 20, and a carrier 4 that is detachably accommodated inside the apparatus main body 2. And a light source 6 disposed inside the apparatus main body 2.
[0018] 基体 10は、光反射性材料により容器状に形成されており、上部開口が蓋部材 11に より覆われている。光反射性材料としては、可視光反射性を有する材料であれば特 に限定されないが、例えば、アクリル樹脂、ポリエチレン樹脂、ポリカーボネート樹脂 などの種々の樹脂に、白色の顔料や染料などを分散させたものや、ステンレス、アル ミなどの金属材料を挙げることができる。  The base 10 is formed in a container shape from a light reflective material, and the upper opening is covered with a lid member 11. The light reflective material is not particularly limited as long as it is a material having visible light reflectivity. For example, a white pigment or a dye is dispersed in various resins such as an acrylic resin, a polyethylene resin, and a polycarbonate resin. And metal materials such as stainless steel and aluminum.
[0019] 蓋部材 11は、耐熱性及び電気絶縁性に優れた樹脂などから形成することができ、 一部を凹ませることにより、担持体 4を収容可能な収容部 12を備えている。収容部 12 の外周面には、金属製の有底筒状の伝熱体 13が嵌合されており、伝熱体 13の底部 下面側には、 PTCヒータなどの電熱ヒータからなる面状の発熱体 14が密着状態で設 けられている。  [0019] The lid member 11 can be formed of a resin having excellent heat resistance and electrical insulation, and includes a storage portion 12 that can store the carrier 4 by being partially recessed. A metal bottomed cylindrical heat transfer body 13 is fitted to the outer peripheral surface of the housing part 12, and the bottom surface of the bottom part of the heat transfer body 13 has a planar shape made of an electric heater such as a PTC heater. The heating element 14 is installed in close contact.
[0020] また、基体 10は、底部に放出口 10aが形成されており、光源 6は、放出口 10aを介 して下方に向けて誘眠光を放出するように配置されている。誘眠光とは、誘眠作用を 生じさせる光をいい、通常の照明を目的とする光に比べて照度が低い光である。誘 眠光の具体的な照度については、後述する。  [0020] In addition, the base 10 has a discharge port 10a formed at the bottom, and the light source 6 is disposed so as to emit a drowsiness light downward through the discharge port 10a. Awakening light refers to light that causes a sleep-inducing action, and is light that has lower illuminance than light intended for normal illumination. Specific illuminance of the sleeping light will be described later.
[0021] 誘眠光を放出する光源 6として、本実施形態においては緑色発光ダイオードを使用 しているが、蛍光灯、ネオン管、白熱球など他の照明器具を用いてもよい。  In the present embodiment, a green light emitting diode is used as the light source 6 that emits the sleeping light, but other lighting devices such as a fluorescent lamp, a neon tube, and an incandescent bulb may be used.
[0022] 基体 10の側面には、電源プラグ 16及びスィッチ 17が設けられており、電源プラグ 1 6を介して発熱体 14及び光源 6に通電可能に構成されている。本実施形態において は、スィッチ 17の操作により、発熱体 14及び光源 6への通電がー体的に行われるよ うに構成している力 S、発熱体 14及び光源 6への通電を個別に行えるように構成しても よい。  [0022] A power plug 16 and a switch 17 are provided on the side surface of the base 10, and the heating element 14 and the light source 6 can be energized via the power plug 16. In the present embodiment, the operation of the switch 17 allows the power S configured to energize the heating element 14 and the light source 6 in a body, and the energization of the heating element 14 and the light source 6 can be performed individually. You may comprise as follows.
[0023] カバー部 20は、光透過性材料からなり、基体 10の全体を覆うように配置され、開口 部 20a, 20bを介して、電源プラグ 16及びスィッチ 17をそれぞれ突出させている。光 透過性材料としては、少なくとも誘眠光を外部において視認可能な程度の可視光透 過性を有する材料であれば特に限定されなレ、が、例えば、アクリル、ポリカーボネート 、ポリプロピレン、ポリ塩ィ匕ビニルなどの光透過性樹脂や、セラミックス、ガラスなどを 例示することができ、更に、これらの樹脂に顔料や染料を適量分散させた樹脂や、磨 りガラスなど、光半透過性材料も含まれる。 [0023] The cover portion 20 is made of a light-transmitting material, is disposed so as to cover the entire base 10, and the power plug 16 and the switch 17 protrude through the openings 20a and 20b, respectively. light The transmissive material is not particularly limited as long as it is a material having at least visible light translucency so that the sleeping light can be visually recognized outside. For example, acrylic, polycarbonate, polypropylene, polyvinyl chloride vinyl, etc. Examples of such a light transmissive resin, ceramics, glass, and the like, and a light semi-transmissive material such as a resin in which an appropriate amount of a pigment or a dye is dispersed in these resins, or polished glass are also included.
[0024] カバー部 20に対する基体 10の位置決めは、電源プラグ 16が開口部 20aに嵌合す ることにより行われ、この状態で基体 10とカバー部 20との間には、全体にわたって隙 間が形成される。カバー部 20は、基体 10の上部を着脱自在に覆うキャップ 21を備え ており、キャップ 21を外した状態で、収容部 12に担持体 4を収容することができる。キ ヤップ 21における収容部 12の直上には、担持体 4の薬剤を外部に蒸散させる蒸散 口 22が形成されている。カバー部 20の側面には、複数の通気口 23が形成されてお り、蒸散口 22からの薬剤の蒸散に伴い、基体 10とカバー部 20との間に外気が導入 される。 [0024] Positioning of the base body 10 with respect to the cover part 20 is performed by fitting the power plug 16 into the opening 20a. In this state, there is a gap between the base body 10 and the cover part 20 over the whole. It is formed. The cover part 20 includes a cap 21 that detachably covers the upper part of the base body 10, and the carrier 4 can be accommodated in the accommodating part 12 with the cap 21 removed. A transpiration port 22 for evaporating the medicine of the carrier 4 to the outside is formed immediately above the accommodating portion 12 in the cap 21. A plurality of vent holes 23 are formed on the side surface of the cover part 20, and outside air is introduced between the base body 10 and the cover part 20 as the medicine evaporates from the evaporating hole 22.
[0025] 担持体 4は、フェルトやパルプなどからなる棒状の部材であり、先端部が僅かに突 出するように収容部 12に収容される。担持体 4には、殺虫剤、殺菌剤、芳香剤、消臭 剤などの液状の各種薬剤に適宜添加剤を含むものを含浸させることが可能であるが 、本実施形態においては、誘眠作用を生じる芳香成分を少なくとも含む薬剤を含浸 させたものを使用する。このような芳香成分としては、「サンダルウッド」、「パイン」など のゥッディー系香料が特に好適である。  [0025] The carrier 4 is a rod-like member made of felt, pulp, or the like, and is accommodated in the accommodating portion 12 so that the tip portion protrudes slightly. The carrier 4 can be impregnated with various liquid chemicals such as insecticides, bactericides, fragrances, deodorants and the like containing additives as appropriate. Use a product impregnated with a chemical containing at least the resulting fragrance component. As such a fragrance component, woody fragrances such as “sandalwood” and “pine” are particularly suitable.
[0026] 担持体 4の材料は、フェルトやパルプ以外に、木綿、レーヨン、アセテート、合成樹 脂(ポリエチレン、ポリプロピレン、ポリエチレン +ポリプロピレン混合物、ポリエチレン テレフタレート、メラミン等)、不織布、石綿、無機質成型物等を例示することができる 、特に、フェルト芯、素焼芯、パルプ芯、合成樹脂芯または無機質成型芯が好まし レ、。また、担持体 4の形状は、本実施形態のような棒状のものに限られず、平板状、リ ング状など種々の形状とすることが可能である。  [0026] In addition to felt and pulp, the material of the carrier 4 is cotton, rayon, acetate, synthetic resin (polyethylene, polypropylene, polyethylene + polypropylene mixture, polyethylene terephthalate, melamine, etc.), non-woven fabric, asbestos, inorganic molding, etc. In particular, a felt core, an unglazed core, a pulp core, a synthetic resin core, or an inorganic molded core is preferred. In addition, the shape of the carrier 4 is not limited to the rod-like shape as in the present embodiment, and may be various shapes such as a flat plate shape and a ring shape.
[0027] 以上の構成を備える薬剤蒸散装置 1によれば、装置本体 2の収容部 12に担持体 4 を収容した状態で、家庭やオフィスなどの壁面に設置されたコンセントに電源プラグ 1 6を差し込むことにより、発熱体 14及び光源 6に通電可能となる。 [0028] 発熱体 14は、伝熱体 13及び収容部 12を介して担持体 4を加熱する。これにより、 担持体 4に含浸された芳香成分の蒸発が促され、蒸発した芳香成分は、蒸散口 22を 介して外部に蒸散する。 [0027] According to the chemical evaporation apparatus 1 having the above-described configuration, the power plug 16 is connected to an outlet installed on the wall surface of a home or office in a state where the carrier 4 is accommodated in the accommodating portion 12 of the apparatus body 2. By inserting, the heating element 14 and the light source 6 can be energized. The heating element 14 heats the carrier 4 via the heat transfer body 13 and the accommodating portion 12. As a result, evaporation of the aroma component impregnated in the support 4 is promoted, and the evaporated aroma component is evaporated to the outside through the evaporation port 22.
[0029] また、光源 6からは、基体 10の底部から下方に向けて、誘眠光が基体 10とカバー 部 20との間に放出される。この誘眠光は、基体 10とカバー部 20との隙間において、 光反射性材料からなる基体 10の表面で反射を繰り返しながら光透過性材料からなる カバー部 20を透過することにより、カバー部 20の全体から外部に放出される。  [0029] Further, from the light source 6, the sleeping light is emitted between the base 10 and the cover part 20 from the bottom of the base 10 downward. This slumber light passes through the cover part 20 made of a light-transmitting material while being repeatedly reflected on the surface of the base substance 10 made of a light-reflective material in the gap between the base body 10 and the cover part 20, thereby Released from the whole to the outside.
[0030] このように、本実施形態の薬剤蒸散装置 1は、芳香成分の蒸散による誘眠作用と、 誘眠光の放出による誘眠作用との相乗効果により、誘眠作用を効果的に高めること が可能である。  [0030] As described above, the drug transpiration apparatus 1 of the present embodiment can effectively enhance the arousal action by the synergistic effect of the arousal action by the transpiration of the aromatic component and the arousal action by the release of the arousal light. is there.
[0031] 後述する本発明者らの実験結果によれば、特定の色相及び照度を有する誘眠光と 、特定の芳香成分との組み合わせにより、顕著な誘眠効果が得られることが明らかに なった。すなわち、カバー部 20を透過した誘眠光の色相は、 PCCS色相環で色相番 号 7〜 15 (黄〜深緑)であることが好ましぐ色相番号 11〜: 13 (緑)がより好ましい。ま た、誘眠光の照度については、大きすぎると誘眠効果を妨げるおそれがある一方、小 さすぎると芳香に誘眠光を組み合わせることの効果が得にくくなることから、 11から 3 6ルクスであることが好ましぐ 11から 23ルクスであることがより好ましレ、。ここで、誘眠 光の照度とは、環境照度が 6ルクス以下の場合に、薬剤蒸散装置 1のカバー部 20表 面における光源 6から最も近い位置 Pから、誘眠光の放出方向に 5cm離れた位置で 、照度計(品番「ANA—F9」、 TOKYO  [0031] According to the results of experiments conducted by the present inventors described later, it has been clarified that a remarkable arousal effect can be obtained by a combination of the arousal light having a specific hue and illuminance and a specific aroma component. That is, the hue of the sleeping light transmitted through the cover part 20 is more preferably a hue number 11 to 13 (green) which is preferably a hue number of 7 to 15 (yellow to dark green) in the PCCS hue ring. On the other hand, if the light intensity of the hypnotic light is too large, it may interfere with the hypnotic effect, while if it is too small, the effect of combining the hypnotic light with fragrance is difficult to obtain. Is more preferred to be 11 to 23 lux. Here, the illuminance of the sleeping light is the position 5 cm away from the position P closest to the light source 6 on the cover 20 surface of the chemical transpiration device 1 when the ambient illumination is 6 lux or less. In illuminance meter (part number "ANA-F9", TOKYO
PHOTO-ELECTRIC CO.LTD.製)により測定した値である。誘眠光の照度は、通電 する光源 6の数や、光源 6への通電量を制御可能なスィッチなどの光度調整手段を 設けることにより、調整可能に構成してもよぐこれによつて、環境照度や個人差に応 じて照度を最適な値に設定することができる。  This is a value measured by PHOTO-ELECTRIC CO.LTD. The illuminance of the sleeping light can be configured to be adjustable by providing a light intensity adjustment means such as a switch that can control the number of light sources 6 to be energized and the amount of power to be applied to the light sources 6. The illuminance can be set to an optimal value according to the illuminance and individual differences.
[0032] このような色相及び照度を有する誘眠光の下で、ゥッディー系香料成分を蒸散させ ることにより、特に大きな誘眠効果を奏することができる。ゥッディー系の香料としては 、サンダルウッド、セダーウッド、パイン、グアイアツク、ベンゾイン、アビエス、ひば、ひ のき、クロモジなどを例示することができる。これらに例示される植物由来の精油の抽 出部位は、樹木の幹及び根である。 [0032] By evaporating the woody perfume component under such arousal light having hue and illuminance, a particularly great arousal effect can be achieved. Examples of woody fragrances include sandalwood, cedarwood, pine, guaiatuk, benzoin, abies, lava, cypress, and black moji. Extraction of plant-derived essential oils exemplified in these The exit site is the trunk and root of the tree.
[0033] このような香料の種類と誘眠光の色相及び強度との最適な組み合わせは、それぞ れを個別に最適化したもの同士を単に組み合わせて得られるものではない。特に、 P CCS色相環で色相番号が 7〜: 15の光は、黄〜深緑の色にほぼ対応するものであり 、従来においては入眠を阻害するものとして知られていたが、光の照度を従来よりも 大幅に低く設定すると共にゥッディー系の香料と組み合わせることにより、顕著な誘 眠効果が得られるという知見は、本発明者らが多種多様な組み合わせによる実験を 行うことによって初めて得られたものである。  [0033] Such an optimal combination of the type of fragrance and the hue and intensity of the awakening light is not obtained by simply combining those individually optimized. In particular, the light with a hue number of 7 to 15 in the PCCS hue ring corresponds to the color of yellow to dark green and has been conventionally known as an obstacle to falling asleep. The knowledge that a remarkable arousal effect can be obtained by setting it significantly lower than before and combining it with woody fragrances was first obtained by the present inventors conducting experiments with various combinations. It is.
[0034] また、本実施形態においては、カバー部 20の全体が、誘眠光を外部に放出する光 透過部を構成している力 一部のみに光透過部を構成してもよい。いずれの場合に おいても、光透過部には、光源 6からの誘眠光を散乱させる散乱部を設けてもよぐこ れによって、散乱部の全体から柔らかな光を略均一に放出することが可能になり、誘 眠効果を高めることができる。ここで「散乱」とは、誘眠光が散乱部において屈折また は反射して種々の方向に拡散する現象をいう。散乱部の具体例としては、光透過部 において光半透過性材料により形成された部分を含む構成、光透過部の内面側及 び外面側の一方又は双方に施された凹凸部を含む構成、光透過部を構成する光透 過性樹脂やガラスなどの内部に散在させた微細な粒子を含む構成などを挙げること ができ、これらの 2つ以上を組み合わせた構成であってもよい。微細な粒子には、顔 料、染料、気泡などが含まれる。  In the present embodiment, the entire cover portion 20 may constitute the light transmission portion only in a part of the force constituting the light transmission portion that emits the sleeping light to the outside. In any case, the light transmitting part may be provided with a scattering part that scatters the sleeping light from the light source 6, so that soft light can be emitted substantially uniformly from the entire scattering part. It becomes possible and can enhance the awakening effect. Here, “scattering” refers to a phenomenon in which awakening light is refracted or reflected at the scattering portion and diffused in various directions. Specific examples of the scattering portion include a configuration including a portion formed of a light translucent material in the light transmission portion, a configuration including an uneven portion provided on one or both of the inner surface side and the outer surface side of the light transmission portion, Examples thereof include a structure containing fine particles dispersed inside a light transmissive resin or glass constituting the light transmissive part, and a structure in which two or more of these are combined may be used. Fine particles include pigments, dyes, and bubbles.
[0035] また、光透過部の可視光透過率は、高すぎると装置本体 2の内部で可視光がほと んど反射せずに外部に放出されるため、光透過部全体からの放出が困難になる一 方、小さすぎると照度が低下するおそれがあることから、 40〜80%力 S好ましく、 50〜 70%がより好ましい。  [0035] If the visible light transmittance of the light transmitting part is too high, visible light is hardly reflected inside the apparatus body 2 and is emitted to the outside. On the other hand, if it is too small, the illuminance may decrease, so 40-80% force S is preferable, and 50-70% is more preferable.
[0036] 以上、本発明の一実施形態について詳述したが、本発明の具体的な態様は上記 実施形態に限定されなレ、。例えば、本実施形態においては、発熱体 14に通電して 担持体 4を加熱することにより、担持体 4に含浸された薬剤の蒸散を促すように構成し ているが、発熱体 14を設けずに、担持体 4に含浸された薬剤の芳香成分を自然蒸散 させるように構成することぁ可肯である。 [0037] また、本実施形態においては、光反射性材料からなる基体 10と、光透過性材料か らなるカバー部 20との間に隙間を形成し、基体 10の底部から下方に向けて誘眠光 を放出することにより、カバー部 20全体からの放出を促して、芳香と誘眠光との組み 合わせによる誘眠効果を確実に得られるように構成しているが、誘眠光を放出する光 源 6の配置は必ずしも本実施形態のものに限定されず、例えば、基体 10の側部から 基体 10とカバー部 20との隙間に誘眠光を放出するように、光源 6を配置してもよい。 更に、カバー部 20は必ずしも必要ではなぐこれを設けない構成とすることも可能で ある。 [0036] Although one embodiment of the present invention has been described in detail above, specific aspects of the present invention are not limited to the above-described embodiment. For example, in the present embodiment, the heating element 14 is energized to heat the carrier 4 to promote the evaporation of the drug impregnated in the carrier 4, but the heating element 14 is not provided. In addition, it is acceptable to configure the fragrance component of the drug impregnated in the carrier 4 to spontaneously evaporate. [0037] In the present embodiment, a gap is formed between the base 10 made of a light-reflective material and the cover 20 made of a light-transmitting material, and the user is asleep from the bottom of the base 10 downward. By emitting light, it is configured to promote the release from the entire cover part 20 and to ensure the awakening effect by combining the fragrance and the awakening light, but the light source that emits the awakening light 6 The arrangement of the light source 6 is not necessarily limited to that of the present embodiment. For example, the light source 6 may be arranged so as to emit the sleeping light from the side portion of the base body 10 into the gap between the base body 10 and the cover part 20. Furthermore, the cover portion 20 may be configured not to be provided as it is not necessary.
[0038] また、本実施形態においては、光源 6を一つ配置している力 光源 6を複数配置し てもよレ、。この場合でも、上記のような散乱部を備える構成とすることにより、ほんのり と全体を優しく光らせることができる。  [0038] In the present embodiment, a single light source 6 is arranged. A plurality of light sources 6 may be arranged. Even in this case, it is possible to make the whole light gently by adopting the configuration including the scattering portion as described above.
[0039] また、本発明の他の実施形態として、図 3に示す構成を挙げることができる。図 3に おいて、図 1及び図 2と同様の構成部分には同一の符号を付して、詳細な説明を省 略する。 Further, as another embodiment of the present invention, a configuration shown in FIG. 3 can be exemplified. In FIG. 3, the same components as those in FIGS. 1 and 2 are denoted by the same reference numerals, and detailed description thereof is omitted.
[0040] 薬剤蒸散装置 100は、棒状の担持体 4を保持する薬剤容器 40を、本体部 201及 びカバー部 202からなる装置本体 200の内部に収容することにより構成されている。 装置本体 200は、本体部 201が光反射性材料からなる一方、カバー部 202が光透 過性材料からなり、カバー部 202が、装置本体 200の光透過部を構成する。また、薬 剤容器 40は、例えばガラスにより構成することができ、内部に芳香成分を有する液状 の薬剤 Lが貯留されている。  [0040] The drug transpiration apparatus 100 is configured by accommodating a drug container 40 holding a rod-shaped carrier 4 in an apparatus main body 200 including a main body 201 and a cover 202. In the apparatus main body 200, the main body section 201 is made of a light reflecting material, the cover section 202 is made of a light transmitting material, and the cover section 202 constitutes a light transmitting section of the apparatus main body 200. The drug container 40 can be made of glass, for example, and stores a liquid drug L having an aromatic component therein.
[0041] 本体部 201は、担持体 4及び薬剤容器 40の上部を所定の位置に保持する保持部 201aを備えており、更に、加熱ヒータ 201b及びファン 201cを備えている。また、力 バー部 202は、ファン 201cと対向する位置に蒸散口 22が形成されており、本体部 2 01に嵌合されている。カバー部 202の内面側には、光源 6及び突片 202aとが設けら れており、突片 202aは、薬剤容器 40の側壁外面に形成された係合部と係合する。 薬剤容器 40は、本体部 201とカバー部 202との間に下方から揷入可能であり、突片 202aとの係合によって着脱自在に支持される。  [0041] The main body 201 includes a holding unit 201a that holds the upper portion of the carrier 4 and the drug container 40 at predetermined positions, and further includes a heater 201b and a fan 201c. Further, the force bar portion 202 has a transpiration port 22 formed at a position facing the fan 201c, and is fitted to the main body portion 201. A light source 6 and a projecting piece 202a are provided on the inner surface side of the cover part 202, and the projecting piece 202a is engaged with an engaging part formed on the outer side surface of the side wall of the medicine container 40. The medicine container 40 can be inserted between the main body portion 201 and the cover portion 202 from below, and is detachably supported by engagement with the protruding piece 202a.
[0042] 光透過部を構成するカバー部 202は、光源 6側からみて内側に湾曲するように形 成されており、光源 6の誘眠光がカバー部 202の全体から放出し易いように構成され ている。 [0042] The cover part 202 constituting the light transmission part is shaped so as to bend inward as viewed from the light source 6 side. It is configured so that the sleep light of the light source 6 can be easily emitted from the entire cover portion 202.
[0043] カバー部 202の外面には、意匠シート 50が装着されている。意匠シート 50は、光 透過性樹脂やガラスなどの光透過性材料からなるシートに、図柄や写真などを印刷 や貼着などの手段で施すことにより形成され、側縁に設けられた差込片(図示せず) をカバー部 202の差込スリット(図示せず)に揷入することにより、カバー部 202に密 着するように保持される。カバー部 202への意匠シート 50の装着は、取り外し可能で あってもよく、或いは、一体化されていてもよい。  A design sheet 50 is attached to the outer surface of the cover portion 202. The design sheet 50 is formed by applying a design or a photograph to a sheet made of a light transmissive material such as a light transmissive resin or glass by means of printing or sticking, and is provided on a side edge. By inserting (not shown) into an insertion slit (not shown) of the cover portion 202, the cover portion 202 is held so as to be tightly attached. The design sheet 50 may be attached to the cover portion 202 in a removable manner or may be integrated.
[0044] カロ熱ヒータ 201b、ファン 201c及び光源 6は、電源プラグ 16を壁面のコンセントに装 着することで、スィッチ 17の操作により通電される。  [0044] The calo heat heater 201b, the fan 201c, and the light source 6 are energized by the operation of the switch 17 by attaching the power plug 16 to the wall outlet.
[0045] 以上の構成を有する薬剤蒸散装置 100によれば、担持体 4が、薬剤容器 40の薬剤 Uこ浸漬された状態で装置本体 200に収容されており、蒸散させる薬剤を薬剤容器 40から吸い上げて補充することができる。したがって、光源 6による誘眠光の放出と 薬剤の蒸散との組み合わせによる誘眠効果を長時間維持することができる。  [0045] According to the drug evaporation apparatus 100 having the above configuration, the carrier 4 is accommodated in the apparatus main body 200 in a state where the drug U is immersed in the drug container 40, and the drug to be evaporated is supplied from the drug container 40. Can be sucked up and refilled. Therefore, it is possible to maintain the awakening effect for a long time by combining the release of the awakening light by the light source 6 and the transpiration of the drug.
[0046] また、光透過部には意匠シート 50が配置されているので、所望の図柄や写真を誘 眠光により浮き上がらせて、意匠的な効果からも誘眠作用を促すことができる。  [0046] Further, since the design sheet 50 is arranged in the light transmitting portion, a desired design or photograph can be lifted by the wake-up light, and the wake-up action can be promoted from the design effect.
[0047] また、薬剤蒸散装置 100における透過部は、装置本体 200の一部に形成されたも のであり、光源 15を挟んで電源プラグ 16と反対側に形成されているので、電源プラ グ 16を壁面のコンセントに装着した際に、睡眠姿勢の使用者に対して誘眠光を確実 に放出することができる。  [0047] Further, the transmission part in the chemical evaporation apparatus 100 is formed in a part of the apparatus main body 200, and is formed on the opposite side of the power plug 16 with the light source 15 interposed therebetween. When the is attached to a wall outlet, it is possible to reliably emit a wake-up light to a user in sleep posture.
実施例  Example
[0048] 以下、実施例に基づいて本発明を更に詳細に説明する。但し、本発明は、以下の 実施例に限定されるものではない。  [0048] Hereinafter, the present invention will be described in more detail based on examples. However, the present invention is not limited to the following examples.
[0049] (実施例 1) [0049] (Example 1)
香料の種類と誘眠光の色相との種々の組み合わせに対する誘眠効果の違いを調 ベるため、以下の実験を行った。  In order to investigate the difference in the arousal effect for various combinations of the fragrance type and the color of the arousal light, the following experiment was conducted.
[0050] 被験者が恒温恒湿室の中央に設置した椅子に着席した状態で、本願の図 1及び 図 2に示す薬剤蒸散装置を用いて、 PCCS色相環での色相番号に基づく 7種類の誘 眠光、及び、 6種類の香りの組み合わせを被験者に提示し、 5分後におけるリラックス の程度を、被験者の自己申告により数値化した。 [0050] Seven kinds of invitations based on the hue number in the PCCS hue ring using the chemical evaporation apparatus shown in Figs. 1 and 2 of the present application while the subject is seated in a chair installed in the center of the constant temperature and humidity chamber. The subjects were presented with a combination of drowsiness and six fragrances, and the degree of relaxation after 5 minutes was quantified by the self-report.
[0051] 恒温恒湿室は、温度を 23. 5〜24. 2°C、湿度を 43〜46%にそれぞれ維持し、環 境照度を 0〜6ルクスとした。また、誘眠光の照度は、図 2の P点力 鉛直下方に 5cm の位置で 23ルクスに設定し、薬剤蒸散装置から被験者までの距離は、 0. 5〜: 1. Om の範囲に設定した。 [0051] The temperature and humidity chamber was maintained at a temperature of 23.5 to 24.2 ° C, a humidity of 43 to 46%, and an ambient illuminance of 0 to 6 lux. In addition, the illuminance of the awakening light was set to 23 lux at a position 5 cm vertically below the P point force in Fig. 2, and the distance from the drug transpiration device to the subject was set in the range of 0.5 to 1. Om. .
[0052] 誘眠光は、赤色に対応する色相番号:!〜 3、橙色に対応する色相番号 4〜6、黄色 に対応する色相番号 7〜: 10、緑色に対応する色相番号 11〜: 13、深緑色に対応する 色相番号 14〜: 15、青色に対応する色相番号 16〜19、紫色に対応する色相番号 2 0〜 24の合計 7種類とし、香料は、ゥッディー系の香料として「サンダルウッド」及び「 パイン」、ハーブ系の香料として「ラベンダー」及び「ゼラユウム」、フローラル系の香料 として「ローズ」及び「リンデン」の合計 6種類とした。誘眠光の色相番号の特定は、図 2の P点に白色紙 (Askul社 マルチペーパースーパーエコノミー(秤量:約 64g/m2 紙厚:約 90 / m 白色度:約 87%) )を貼り合わせ、この白色紙に対して光源 6と反対側 の位置から、白色紙に写る色を 5名のパネラーが目視評価することで行った。 [0052] The hypnotic light has hue numbers corresponding to red:! To 3, hue numbers corresponding to orange 4 to 6, hue numbers 7 to 10 corresponding to yellow, hue numbers 11 to 13 corresponding to green, Hue number 14 ~: 15 corresponding to dark green, hue number 16 ~ 19 corresponding to blue, hue number 20 ~ 24 corresponding to purple, a total of 7 types, and fragrance is “Sandalwood” as woody fragrance And “Pine”, “lavender” and “Gerayuum” as herbal flavors, and “Rose” and “Linden” as floral flavors. To identify the hue number of the hypnotic light, paste white paper (Askul Multi-Paper Super Economy (weight: approx. 64g / m 2 paper thickness: approx. 90 / m whiteness: approx. 87%)) to point P in Figure 2. From the position opposite to the light source 6 with respect to this white paper, the colors appearing on the white paper were visually evaluated by five panelists.
[0053] リラックスの程度は 7段階で評価し、とてもリラックスできた場合を「6点」、リラックスで きた場合を「5点」、どちらかといえばリラックスできた場合を「4点」、リラックスできたか 否かどちらとも言えない場合を「3点」、あまりリラックスできなかった場合を「2点」、リラ ックスできなかった場合を「1点」、全くリラックスできなかった場合を「0点」とした。 尚、本発明者らは、このようにして測定したリラックスの程度が誘眠効果の程度と相関 関係を有することを、事前に確認している。  [0053] The degree of relaxation is rated on a 7-point scale, with 6 points when you are very relaxed, 5 points when you are relaxed, and 4 points when you are relaxed. “3 points” if you couldn't say whether or not, “2 points” if you could n’t relax, “1 points” if you could n’t relax, and “0 points” if you could n’t relax at all. did. The present inventors have confirmed in advance that the degree of relaxation measured in this way has a correlation with the degree of the hypnotic effect.
[0054] この実験結果を図 4に示す。図 4から明らかなように、香料が「サンダルウッド」及び「 パイン」のゥッディー系香料であり、且つ、誘眠光が黄色光、緑色光または深緑色光 である場合 (すなわち、色相番号が 7〜: 15)に、他の香料及び誘眠光の組み合わせ と比較して大きなリラックス効果 (誘眠効果)が得られており、特にゥッディー系香料と 緑色光(すなわち、色相番号が 11〜13)との組み合わせにおいて、より顕著なリラッ タス効果 (誘眠効果)が得られている。この結果から、同じくゥッディー系の香料である セダーウッド、グアイアツク、ベンゾイン、アビエス、ひば、ひのき、クロモジなどについ ても、色相番号が 7〜: 15の誘眠光との組み合わせにより、顕著な誘眠効果を奏する ものと推測される。 [0054] Fig. 4 shows the results of this experiment. As is clear from FIG. 4, when the fragrance is a woody fragrance of “Sandalwood” and “Pine”, and the awakening light is yellow light, green light or dark green light (that is, the hue number is 7 to : 15) has a large relaxing effect (sleeping effect) compared to other fragrances and a combination of sedative light, especially a combination of woody fragrance and green light (ie, hue number 11-13) In Fig. 3, a more remarkable lattus effect (sleeping effect) was obtained. From this result, it was found that the same woody fragrances such as Cedarwood, Guaiatucu, Benzoin, Abies, Hiba, Hinoki, Chromoji, etc. However, it is presumed that there is a remarkable hypnotic effect when combined with a hypnotic light having a hue number of 7 to 15:
[0055] (実施例 2) [Example 2]
実施例 1と同様の薬剤蒸散装置を用いて、誘眠光の照度が誘眠効果にどのような 影響を与えるかを調べるため、サンダルウッド香料と色相番号が 11〜: 13の誘眠光と の組み合わせに基づき、以下の実験を行った。  In order to investigate how the illuminance of the awakening light has an effect on the arousal effect using the same chemical transpiration apparatus as in Example 1, the combination of the sandalwood fragrance and the aspiration number of 11 to 13 is used. Based on this, the following experiment was conducted.
[0056] 実験は 5名の被験者の各寝室で行い、環境照度を 0〜6ルクスとした。また、薬剤蒸 散装置から睡眠姿勢の被験者までの距離は、 0. 5〜: 1. Omの範囲に設定した。誘眠 光の照度は、図 2の P点から鉛直下方に 5cmの位置で測定し、異なる照度で被験者 が実際に睡眠をとつた後、被験者には、「中高年 ·高齢者を対象とした OSA睡眠調査 票 (MA版)の開発と標準化 脳と精神の医学 第 10卷第 4号 1999年」に従って、起床 直後に「OSA睡眠調査票 MA版」への記入を依頼した。  [0056] The experiment was performed in the bedrooms of five subjects, and the ambient illuminance was 0 to 6 lux. In addition, the distance from the drug evaporating device to the sleeping subject was set in the range of 0.5 to: 1. Om. The illuminance of the hypnotic light is measured at a position 5 cm vertically downward from the point P in Fig. 2. After the subject actually took sleep at different illuminance, the subject was asked to `` OSA sleep for middle-aged and elderly people. Development and Standardization of Survey Form (MA Version) In accordance with Brain and Psychiatric Medicine No. 10 No. 4, 1999, we requested that the “OSA Sleep Survey Form MA Version” be completed immediately after waking up.
[0057] 「OSA睡眠調査票 MA版」は、「疲れが残っている」、「集中力がある」など 20の質問 項目力 構成されており、それぞれ 4つの選択肢から選択して記入する。この結果か ら、睡眠に関する 5つの因子 (起床時眠気、入眠と睡眠維持、夢み、疲労回復、睡眠 時間)のそれぞれについて得点を算出することができる。各因子について、被験者 5 名の平均得点を照度毎に算出した結果を図 5に示す。  [0057] The “OSA Sleep Survey Form MA version” consists of 20 questions, including “Remaining fatigue” and “Concentration”. Each item is selected from four options. From these results, scores can be calculated for each of the five sleep-related factors (wake-up sleepiness, falling asleep and sleep maintenance, dreams, recovery from fatigue, and sleep time). Figure 5 shows the results of calculating the average score of five subjects for each factor for each illuminance.
[0058] 実験に際しては、食事と入浴の時刻を指定し、食事についてはコーヒーや紅茶など カフェインを含有する食品、バナナやチーズなどのカテコールアミンを含有する食品 、およびアルコールを含有する食品の摂取は控えるよう 指示した。また日中におい て昼寝および過度の激しい運動は行わないことを指示し、 自宅以外では就寝しない こと、就寝時刻を 22時から 0時の間とすること、起床時刻を 6時から 8時の間とするよう に指示した。こうして、被験者の眠気が実験日によってばらつきを生じないようにした  [0058] In the experiment, the time of meal and bathing is specified, and for food, food containing caffeine such as coffee and tea, food containing catecholamines such as banana and cheese, and food containing alcohol I ordered to refrain. Also, instruct the person not to take a nap or excessive exercise during the day, not to go to bed outside the home, set the bedtime between 22:00 and 00:00, and set the bedtime between 6 and 8 I directed. In this way, the subject's sleepiness did not vary from day to day.
[0059] 図 5において、条件 2〜6は、誘眠光の照度がそれぞれ 0ルクス、 11ノレタス、 23ルク ス、 36ルクス、 45ルクスの場合を示している。また、条件 1は、これらに対する比較例 であり、誘眠光及び香料をいずれも使用しない場合である。図 5から明らかなように、 誘眠効果と関連性が高い第 2因子 (入眠と睡眠維持)については、照度が 11〜36ル タスの範囲で良好な誘眠効果が得られており、特に照度が 11〜23ルクスの範囲で 顕著である。照度が 11〜23ルクスの場合は、他の照度の場合と比較して、第 1因子( 起床時眠気)や第 4因子 (疲労)に関しても、改善効果を確認することができた。 [0059] In FIG. 5, conditions 2 to 6 indicate cases where the illuminance of the sleeping light is 0 lux, 11 norletus, 23 lux, 36 lux, and 45 lux, respectively. Condition 1 is a comparative example for these cases, in which neither the sleeping light nor the fragrance is used. As is clear from Fig. 5, the illuminance of the second factor (sleeping and sleep maintenance), which is highly related to the hypnotic effect, is 11 to 36 lux. A good hypnotic effect is obtained in the range of tuss, especially in the range of 11 to 23 lux. When the illuminance was 11 to 23 lux, the improvement effect was also confirmed for the first factor (wake-up sleepiness) and the fourth factor (fatigue) compared to other illuminance cases.
図面の簡単な説明 Brief Description of Drawings
[図 1]本発明の一実施形態に係る薬剤蒸散装置の平面図である。 FIG. 1 is a plan view of a chemical transpiration apparatus according to an embodiment of the present invention.
[図 2]—部を図 1の A— A断面で示す側面図である。 [FIG. 2] is a side view showing the section in the AA section of FIG.
[図 3]本発明の他の実施形態に係る薬剤蒸散装置を一部断面で示す側面図である。  FIG. 3 is a side view showing in partial cross section a drug transpiration apparatus according to another embodiment of the present invention.
[図 4]本発明による誘眠効果を示す実験データである。 [Fig. 4] Experimental data showing the effect of the present invention on hypnosis.
[図 5]本発明による誘眠効果を示す他の実験データである。 FIG. 5 is another experimental data showing the effect of sleeping according to the present invention.
符号の説明 Explanation of symbols
1 薬剤蒸散装置  1 Chemical transpiration device
2 装置本体  2 Main unit
4 担持体  4 Carrier
6 光源  6 Light source
10 基体  10 substrate
12 収容部  12 containment
14 発熱体  14 Heating element
16 電源プラグ  16 Power plug
20 カバー部  20 Cover section
22 蒸散口  22 Transpiration mouth
40 薬剤容器  40 drug containers
50 意匠シート  50 Design sheet

Claims

請求の範囲 The scope of the claims
[1] 芳香成分を含有する薬剤を含浸させた担持体と、  [1] a carrier impregnated with a drug containing an aromatic component;
前記担持体を収容する装置本体と、  An apparatus main body for accommodating the carrier;
前記装置本体の内部に配置された光源とを備え、  A light source disposed inside the apparatus body,
前記装置本体は、前記芳香成分を外部に蒸散させるための蒸散口と、前記光源か ら放出された誘眠光を外部に透過する光透過部とを有し、  The apparatus main body has a transpiration port for transpiration of the fragrance component to the outside, and a light transmission part that transmits the wakefulness light emitted from the light source to the outside,
前記光透過部を透過した誘眠光は、照度が 11〜36ルクスであり、且つ、色相が!3 CCS色相環で色相番号 7〜: 15であり、 The awakening light transmitted through the light transmission part has an illuminance of 11 to 36 lux and a hue of 3 CCS hue ring with a hue number of 7 to 15;
前記芳香成分は、ゥッディー系の香料成分を主成分として含む薬剤蒸散装置。  The fragrance component is a chemical transpiration apparatus containing a woody fragrance component as a main component.
[2] 前記装置本体に収容された前記担持体を加熱して前記芳香成分の蒸散を促す発熱 体を更に備える請求項 1に記載の薬剤蒸散装置。 [2] The chemical evaporation apparatus according to [1], further comprising a heating element that heats the carrier accommodated in the apparatus main body and promotes evaporation of the aromatic component.
[3] 液状である前記薬剤を貯留する薬剤容器を更に備え、 [3] It further comprises a drug container for storing the drug in liquid form,
前記担持体は、その一部が前記薬剤容器内の薬剤に浸漬されている請求項 1また は 2に記載の薬剤蒸散装置。  The drug evaporation apparatus according to claim 1 or 2, wherein a part of the carrier is immersed in a drug in the drug container.
[4] 前記光透過部は、前記誘眠光を散乱させる散乱部を備える請求項 1から 3のいずれ かに記載の薬剤蒸散装置。 [4] The drug transpiration apparatus according to any one of claims 1 to 3, wherein the light transmission unit includes a scattering unit that scatters the sleeping light.
[5] 前記散乱部は、前記光透過部において光半透過性材料により形成された部分を含 む請求項 4に記載の薬剤蒸散装置。 5. The drug transpiration apparatus according to claim 4, wherein the scattering portion includes a portion formed of a light semi-transmissive material in the light transmitting portion.
[6] 前記装置本体は、電源プラグを備えており、前記光透過部が、少なくとも前記光源を 挟んで前記電源プラグと反対側に形成されてレ、る請求項 1から 5のレ、ずれかに記載 の薬剤蒸散装置。 [6] The apparatus according to any one of claims 1 to 5, wherein the apparatus main body includes a power plug, and the light transmitting portion is formed on a side opposite to the power plug at least across the light source. The chemical transpiration device described in 1.
[7] 前記装置本体は、光反射性材料からなる基体と、前記光透過部を有するカバー部と を備えており、  [7] The apparatus main body includes a base body made of a light reflective material, and a cover portion having the light transmission portion,
前記カバー部は、前記基体全体を覆うように、前記基体との間に隙間をあけて配置 され、  The cover portion is disposed with a gap between the cover and the base so as to cover the whole base.
前記光源は、前記基体とカバー部との隙間に照明光を放出するように配置される 請求項 1から 6のいずれかに記載の薬剤蒸散装置。  The drug evaporation apparatus according to any one of claims 1 to 6, wherein the light source is disposed so as to emit illumination light into a gap between the base and the cover portion.
[8] 前記光透過部は、曲板状に形成されており、前記光源側からみて内側に湾曲してい ることを特徴とする請求項 1から 7のいずれかに記載の薬剤蒸散装置。 [8] The light transmission portion is formed in a curved plate shape, and is curved inward as viewed from the light source side. The drug transpiration apparatus according to any one of claims 1 to 7, wherein:
PCT/JP2007/059488 2006-05-08 2007-05-08 Chemical transpiration apparatus WO2007129698A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2006-129596 2006-05-08
JP2006129596 2006-05-08
JP2007021969A JP4487147B2 (en) 2006-05-08 2007-01-31 Chemical transpiration device
JP2007-021969 2007-01-31

Publications (1)

Publication Number Publication Date
WO2007129698A1 true WO2007129698A1 (en) 2007-11-15

Family

ID=38667806

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2007/059488 WO2007129698A1 (en) 2006-05-08 2007-05-08 Chemical transpiration apparatus

Country Status (2)

Country Link
JP (1) JP4487147B2 (en)
WO (1) WO2007129698A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9205165B2 (en) 2012-10-22 2015-12-08 S.C. Johnson & Son, Inc. Volatile material dispensing system having an adjustable diffusion apparatus

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6024354Y2 (en) * 1980-12-15 1985-07-20 國新産業株式会社 Scent generator with decorative lighting
JPH01155850U (en) * 1988-04-15 1989-10-26
JPH08111116A (en) * 1994-10-11 1996-04-30 Satoyuki Takabayashi Lighting system for bed
JP3087142U (en) * 2002-01-08 2002-07-19 株式会社日建 Sleep induction device
JP2003052828A (en) * 2001-08-10 2003-02-25 Kao Corp Living space environment improving method
JP2005525897A (en) * 2002-05-13 2005-09-02 エス.シー. ジョンソン アンド サン、インコーポレイテッド Harmonious fragrance, light and sound generation
JP2005270401A (en) * 2004-03-25 2005-10-06 Seiko Epson Corp Bedding with sleep controller
JP2006093012A (en) * 2004-09-27 2006-04-06 Hosiden Corp Lighting device

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6024354Y2 (en) * 1980-12-15 1985-07-20 國新産業株式会社 Scent generator with decorative lighting
JPH01155850U (en) * 1988-04-15 1989-10-26
JPH08111116A (en) * 1994-10-11 1996-04-30 Satoyuki Takabayashi Lighting system for bed
JP2003052828A (en) * 2001-08-10 2003-02-25 Kao Corp Living space environment improving method
JP3087142U (en) * 2002-01-08 2002-07-19 株式会社日建 Sleep induction device
JP2005525897A (en) * 2002-05-13 2005-09-02 エス.シー. ジョンソン アンド サン、インコーポレイテッド Harmonious fragrance, light and sound generation
JP2005270401A (en) * 2004-03-25 2005-10-06 Seiko Epson Corp Bedding with sleep controller
JP2006093012A (en) * 2004-09-27 2006-04-06 Hosiden Corp Lighting device

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9205165B2 (en) 2012-10-22 2015-12-08 S.C. Johnson & Son, Inc. Volatile material dispensing system having an adjustable diffusion apparatus

Also Published As

Publication number Publication date
JP2007325912A (en) 2007-12-20
JP4487147B2 (en) 2010-06-23

Similar Documents

Publication Publication Date Title
TW529959B (en) Articles and systems for dispensing volatile materials into the environment
AU2001243552B2 (en) Night light air freshener
CA2640287C (en) Fragrance emanation system
US8724975B2 (en) Fragrance producing lighting device
ES2272522T3 (en) DISPENSING DEVICE FOR DISPENSING AROMAS.
US5647052A (en) Volatile substance dispenser and method of dispensing a volatile substance with dissipation indication
US8137630B2 (en) Light-emitting smell-altering aroma dispenser
CA2747033C (en) Fragrance producing lighting device
JP5553845B2 (en) Air freshener supplier
US7643734B2 (en) Bottle eject mechanism
US20140334801A1 (en) Fragrance producing lighting device
KR20140090485A (en) Ocher humidifier which far infrared rays emitted
JP4487147B2 (en) Chemical transpiration device
JP4610535B2 (en) Chemical transpiration device
KR200419523Y1 (en) Indoor decoration container for inducing far infrared ray emission and smell induction
KR102040262B1 (en) Mood light of combined with evaporative type electric aroma diffuser
GB2469505A (en) Light-emitting aroma dispenser
KR102048204B1 (en) Container For Repellent Liquid For Electric Mosquito Extirpation Device
JP5100058B2 (en) Chemical transpiration device
KR200387834Y1 (en) Combined type of a (-)ion-aromatic emitting apparatus
TWM253354U (en) Paraphernalia perfume delivery device
BRMU9001130U2 (en) flavor diffuser with chromotherapeutic lights
ITMC20090030U1 (en) AROMA LUMINOUS DISPENSER WITH INTERCHANGEABLE FRAGRANCES.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07742923

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 07742923

Country of ref document: EP

Kind code of ref document: A1